Notice NOT-EB-20-014 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-CA-20-048 from the NIH Guide for Grants and Contracts. The purpose of the NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) is to encourage and retain outstanding graduate students recognized by their institutions for their high potential and strong interest in pursuing careers as independent cancer researchers. The award will facilitate the transition of talented graduate students into successful cancer research postdoctoral appointments, and provide opportunities for career development activities relevant to their long-term career goals of becoming independent cancer researchers. This Funding Opportunity Announcement (FOA) does not allow applicants to propose to lead an independent clinical trial, but does allow applicants to propose research experience in a clinical trial led by a sponsor or co-sponsor.

Funding Opportunity PAR-20-292 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) supports the development of new exploratory research in cancer diagnosis, treatment, imaging, symptom/toxicity, and prevention clinical trials; correlative studies associated with clinical trials; novel cancer therapeutic, symptom/toxicity, and preventive agent development, radiotherapy development activities, and mechanism-driven combinations; and innovative preclinical studies--including the use of new clinically-relevant models and imaging technologies--which could lead to first-in-human clinical trials. The R21 mechanism is intended to encourage exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk, but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of cancer research (pre-clinical or clinical).

Funding Opportunity PAR-20-258 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to provide early-stage investigators with support and protected time (up to five years) for intensive, research-focused career development program activities under the guidance of an experienced mentorship team with expertise in both the preclinical application of nonhuman primate (NHP) models and in translation of the results from such studies to clinical application. The focus of this program is to increase the number of highly skilled scientists using NHP models to address complex translational biomedical research designed to foster translation of outcomes into the clinic. The expectation is that through this sustained period of research career development and training, awardees will launch independent research careers and become competitive for new research project grant (e.g., R01) funding. This Funding Opportunity Announcement (FOA) is designed specifically for candidates proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Under this FOA candidates are permitted to propose a research experience in a clinical trial led by a mentor or co-mentor.

Funding Opportunity RFA-DK-20-022 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support multidisciplinary research teams with complementary expertise in HIV and pathobiology, pathophysiology, and/or metabolism in organs, tissues, and/or biological systems of specific interest to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). These teams will comprehensively interrogate fundamental mechanisms underlying HIV-associated comorbidities, coinfections, and complications relevant to the mission of the NIDDK and advance progress toward alleviating them.

Funding Opportunity RFA-ES-20-013 from the NIH Guide for Grants and Contracts. The purpose of the RESTORE program is to advance understanding of the role of inflammation resolution pathways at the cellular and molecular level and how exposure to environmental pollutants interferes with these pathways resulting in exposure-induced chronic systemic inflammation and ultimately chronic disease conditions. The initial phase of this program is focused on understanding how chronic exposure to air pollution interferes with resolution of inflammation in pulmonary, cardiovascular, and metabolic systems and diseases.

Competitive Salary: F. Hoffmann-La Roche AG: (Senior) Scientists Genetics & Genomics (two positions available) We are looking for a highly motivated (Senior) Scientist to join our Genetics and G Switzerland (CH)

Notice NOT-CA-20-095 from the NIH Guide for Grants and Contracts

Notice NOT-EB-20-016 from the NIH Guide for Grants and Contracts

Notice NOT-EB-20-015 from the NIH Guide for Grants and Contracts

Notice NOT-LM-20-017 from the NIH Guide for Grants and Contracts

Notice NOT-TR-20-034 from the NIH Guide for Grants and Contracts

Notice NOT-HL-20-807 from the NIH Guide for Grants and Contracts

Notice NOT-DA-20-071 from the NIH Guide for Grants and Contracts

Notice NOT-DE-20-031 from the NIH Guide for Grants and Contracts

Notice NOT-HL-20-811 from the NIH Guide for Grants and Contracts

Notice NOT-NS-20-104 from the NIH Guide for Grants and Contracts

Notice NOT-NS-20-105 from the NIH Guide for Grants and Contracts

Notice NOT-DK-20-043 from the NIH Guide for Grants and Contracts

Notice NOT-NS-20-103 from the NIH Guide for Grants and Contracts